Derleme

Neuropsychiatric Symptoms in Parkinson’s Disease Patients

Cilt: 18 Sayı: 3 20 Kasım 2023
PDF İndir
EN TR

Neuropsychiatric Symptoms in Parkinson’s Disease Patients

Abstract

Many physical, cognitive and psychological symptoms can be seen in neurological diseases. Parkinson's disease (PD) is a neurological disorder arising from the degeneration of neurons, is characterized by motor and non-motor symptoms. Along with motor symptoms, psychiatric symptoms that are included in non-motor symptoms can also be seen in PD. PD symptoms, genetic predisposition, side effects of pharmacological treatments, psychosocial factors; can cause psychiatric conditions such as anxiety, depression, impulse control disorder, and psychosis. It has been determined that the most common psychiatric disorder in PD is depression, followed by anxiety. Although the presence of psychiatric comorbidities in PD is high, it is often overlooked by clinicians during the diagnosis and treatment process. These factors should be taken into account in the diagnosis process and treatment strategies of Parkinson's patients should be structured in a multifactorial manner.

Keywords

Parkinson’s Disease , Neuropsychiatric symptoms , Anxiety , Depression , Impulse control disorder , Psychosis

Kaynakça

  1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525-35.
  2. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology. 2000 14;55(9):1358-1463.
  3. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003;157(11):1015-1022.
  4. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry. 2000;68(4):423-428.
  5. Martinez-Martin P. Nonmotor symptoms and health-related quality of life in early Parkinson's disease. Mov Disord. 2014;29(2):166-168.
  6. Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord. 2012;27(5):617-626.
  7. Ertan S, Benbir G. Dopamine Dysregulation Syndrome and other psychiatric problems in Parkinson’s Disease: Diagnosis and Treatment. Turk J Neurol. 2011;17(2): 65-75
  8. Bearn J, Evans A, Kelleher M, Turner K, Lees A. Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study. Drug Alcohol Depend. 2004;76(3):305-310.
  9. Reiff J, Jost WH. Drug-induced impulse control disorders in Parkinson’s disease. J Neurol. 2011;258:S323-327.
  10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.

Kaynak Göster

AMA
1.Kaya T, Tuğan Yıldız B. Neuropsychiatric Symptoms in Parkinson’s Disease Patients. KSÜ Tıp Fak Der. 2023;18(3):105-109. doi:10.17517/ksutfd.1214193